Multiple Ascending Dose Study of GLPG0634 in Japanese and Caucasian Healthy Subjects
Clinical trial NCT02162355 · COMPLETED
Trial details
- NCT number
- NCT02162355
- Sponsor
- Lakefront Biotherapeutics NV
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-01
- Primary completion
- 2014-09-01
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.